What I'm still not totally convinced of is whether AVXT's method will be part of the picture. I found something out this weekend that did give me a confidence boost about AVXT. Dr. Berd, who developed the OVAX and MVAX, now carries the title of national director of immunology at the Cancer Treament Centers of America.
This is of course where the ovarian cancer trial is taking place, so hopefully he'll guide his therapy to approval with the FDA.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM